New drugs on the research horizon could spare people with celiac the pain of accidentally eating pizza or pasta. 

By Amanda B. Keener; Reviewed by Robert Jasmerimgres

More than two million Americans live with celiac disease — an autoimmune digestive disorder in which eating gluten, a combination of proteins commonly found in wheat products, activates immune cells that damage the lining of the intestines. Sticking to a gluten-free diet is currently the only available treatment for celiac disease. However, maintaining a 100-percent gluten-free diet can be very challenging.

The Challenges of Living Gluten-Free

Even with the best intentions, living gluten-free is much easier said than done. It was almost impossible to tell which packaged “gluten-free” foods lived up to their claims until late last year when the U.S. Food and Drug Administration (FDA) began enforcing gluten-free labeling guidelines. And it’s hard to guarantee you won’t accidentally consume gluten at a restaurant or on an occasion such as a well-meaning relative’s dinner party.

And for some, following a gluten-free diet doesn’t guarantee they’ll feel better. A small percentage of celiac patients (about 2 to 5 percent) still experience symptoms.

According to Alessio Fasano, MD, director of the Center for Celiac Research at Massachusetts General Hospital in Boston, the gluten-free diet is “far from being perfect.” It is especially difficult, he says, for frequent travelers, students dependent on cafeterias, and people with other dietary restrictions due to health problems like diabetes.

“No matter how careful you are, there are always times when you need to rely on other people to keep you healthy,” says Kristen Sweet, who was diagnosed with celiac disease about five years ago, at the age of 24. Despite keeping her own kitchen gluten-free, Sweet knows she will always be at risk of exposure unless she sacrifices her social life.

As a trained scientist in genetics, Sweet is also painfully aware of the lack of drugs developed specifically for celiac patients. Though staying gluten-free is effective, one slip-up could mean days of symptoms like abdominal pain, constipation, and fatigue. “The issue is that when you do get ‘glutened,’ there is no solution. There is nothing you can take to lessen the blow,” she says.

Beyond a Gluten-Free Diet

Dr. Fasano says that decades of research are beginning to pay off with new drugs designed to help people with celiac disease go beyond maintaining a gluten-free diet. Here are four drugs now in clinical trials:

ALV003 (Alvine Pharmaceuticals)

  • How it works: ALV003 is a combination of two enzymes that chop up gluten before it has a chance to activate the immune system. It would be taken before or during potential gluten exposure.
  • The evidence: This drug was most recently tested in a phase 2 clinical trial, results of which were published in June 2014 in Gastroenterology. During the trial, 34 volunteers with celiac disease ate 2 grams of gluten each day for six weeks and half of them also took ALV003. The drug prevented intestinal damage seen in biopsies at the end of the trial. Phase 2b, a 12-week trial, is now underway.

 AN-PEP (DSM Food Specialties)

  • How it works: AN-PEP is another enzyme that, essentially, eats gluten. AN-PEP is believed to work best when taken while gluten is still in your stomach.
  • The evidence: AN-PEP was shown to be safe in a small 2013 study published in the World Journal of Gastroenterology. For the study, 16 people ate 7 grams of gluten every day for two weeks and half of them also ate AN-PEP, and half took a placebo. However, the group taking a placebo did not get sick enough during the course of the study to show that the enzyme had any effect, so more research will have to be done.

Larazotide Acetate (Alba Therapeutics)

  • How it works: Larazotide acetate blocks a protein that carries pieces of gluten across the gut, where immune cells can see them. Fasano and his colleagues found that this carrier protein, called zonulin, is overproduced by celiac patients after they eat gluten.
  • The evidence: The most recent trial of larazotide acetate, published in February 2015 in Gastroenterology, was a phase 2 trial of celiac patients on a gluten-free diet. The volunteers who took the drug experienced fewer days with disease symptoms during the 12 week-long study.

Nexvax2 (ImmusanT)

  • How it works: Much like an allergy shot, Nexvax2 exposes the immune system to gluten in a controlled way so that immune cells that are usually activated get turned off or eliminated.
  • The evidence: So far, only a phase 1 trial showing that Nexvax2 is safe has been completed. More research is being done to test whether it is effective.

According to Sheila Crowe, MD, a gastroenterologist at the University of California, San Diego School of Medicine, most of these approaches would not replace the gluten-free diet. The enzymes, for example, can only stop the effects of a few grams of gluten at a time. The average diet contains 10 to 50 grams of gluten per day.

For people like Sweet, that is absolutely fine. “I don’t mind being gluten-free,” she says. She just hopes to have an option to ease the stress of dining out or eating a friend’s home-cooked meal.

The Long Road From Lab to Pharmacy

All of the drugs noted above have a long way to go before they are available for purchase. On March 30, the FDA will host a workshop to discuss what clinical trial results are necessary for a new celiac drug to be approved. For example, some studies have recorded gastrointestinal symptoms, while others focused on intestinal damage seen in biopsies.

Marilyn Grunzweig Geller, chief executive officer of the Celiac Disease Foundation, says she hopes the new standards will “open the floodgates” for more companies to do drug trials for celiac disease and bring hope for a treatment beyond the gluten-free diet closer to reality.

Read the original article here.

Will There Ever Be a Drug for celiac e?